InterPAD - DETAILS

CB-5083, 1542705-92-9, CB5083, CB 5083, 1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide, 1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methylindole-4-carboxamide, 591IV6UL6J, 1-(7,8-Dihydro-4-((phenylmethyl)amino)-5H-pyrano(4,3-d)pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide, 1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide, 1H-Indole-4-carboxamide, 1-(7,8-dihydro-4-((phenylmethyl)amino)-5H-pyrano(4,3-d)pyrimidin-2-yl)-2-methyl-, 1-[4-(BENZYLAMINO)-5H,7H,8H-PYRANO[4,3-D]PYRIMIDIN-2-YL]-2-METHYLINDOLE-4-CARBOXAMIDE, JDP, UNII-591IV6UL6J, CHEMBL3747513, SCHEMBL15421452, EX-A773, CB 5083 [WHO-DD], DTXSID801022542, HMS3873E13, BCP23807, BDBM50500325, MFCD28963914, NSC786100, AKOS025396184, CCG-268805, CS-5405, NSC-786100, NCGC00481317-01, NCGC00481317-03, AC-29018, AS-55872, BC177445, CB-5083?, HY-12861, CB-5083; CB 5083, FT-0700217, S8101

No.	Title	Href
1	Sulforaphane is Synergistic with CB-5083 and Inhibits Colony Formation of CB-5083-Resistant HCT116 Cells. ChemMedChem. 2022 Jun 3;17(11):e202200030. doi: 10.1002/cmdc.202200030.	`Click`

No.

Title

Href

Sulforaphane is Synergistic with CB-5083 and Inhibits Colony Formation of CB-5083-Resistant HCT116 Cells. ChemMedChem. 2022 Jun 3;17(11):e202200030. doi: 10.1002/cmdc.202200030.

Click

Name	CB-5083
PubChem CID	73051434
Molecular Weight	413.5g/mol
Synonyms	CB-5083, 1542705-92-9, CB5083, CB 5083, 1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide, 1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methylindole-4-carboxamide, 591IV6UL6J, 1-(7,8-Dihydro-4-((phenylmethyl)amino)-5H-pyrano(4,3-d)pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide, 1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide, 1H-Indole-4-carboxamide, 1-(7,8-dihydro-4-((phenylmethyl)amino)-5H-pyrano(4,3-d)pyrimidin-2-yl)-2-methyl-, 1-[4-(BENZYLAMINO)-5H,7H,8H-PYRANO[4,3-D]PYRIMIDIN-2-YL]-2-METHYLINDOLE-4-CARBOXAMIDE, JDP, UNII-591IV6UL6J, CHEMBL3747513, SCHEMBL15421452, EX-A773, CB 5083 [WHO-DD], DTXSID801022542, HMS3873E13, BCP23807, BDBM50500325, MFCD28963914, NSC786100, AKOS025396184, CCG-268805, CS-5405, NSC-786100, NCGC00481317-01, NCGC00481317-03, AC-29018, AS-55872, BC177445, CB-5083?, HY-12861, CB-5083; CB 5083, FT-0700217, S8101
Drug Type	Small molecule
Formula	C₂₄H₂₃N₅O₂
SMILES	CC1=CC2=C(C=CC=C2N1C3=NC4=C(COCC4)C(=N3)NCC5=CC=CC=C5)C(=O)N
InChI	1S/C24H23N5O2/c1-15-12-18-17(22(25)30)8-5-9-21(18)29(15)24-27-20-10-11-31-14-19(20)23(28-24)26-13-16-6-3-2-4-7-16/h2-9,12H,10-11,13-14H2,1H3,(H2,25,30)(H,26,27,28)
InChIKey	RDALZZCKQFLGJP-UHFFFAOYSA-N
CAS Number	1542705-92-9
ChEMBL ID	CHEMBL3747513
TTD ID	D08OOJ
Drug Bank ID	DB16874
Toxicity	Organism	Test Type	Route(Dose)
Structure			Download 2D MOL 3D MOL

Pair Name	Sulforaphane, CB-5083
Partner Name	Sulforaphane
Disease Info	[ICD-11: 2B90]	Colon cancer		Investigative
Gene Regulation	Down-regulation	Expression	BCL-xL	hsa598
	Up-regulation	Expression	DDIT3	hsa1649
	Down-regulation	Expression	EGFR	hsa1956
	Down-regulation	Activity	NFKB1	hsa4790
	Up-regulation	Phosphorylation	NFKBIA	hsa4792
	Up-regulation	Expression	RELA	hsa5970
	Down-regulation	Expression	SNAI1	hsa6615
	Down-regulation	Expression	TWIST1	hsa7291
In Vitro Model	HCT 116	Colon carcinoma	Homo sapiens (Human)	CVCL_0291
Result	The combination of Sulforaphane and CB-5083 may be a useful treatment strategy to combat CB-5083 resistance.